Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled time : 13:03 save search
GBT Opens 2021 ACCEL Grant Program, Providing up to $500,000 in Support to the Sickle Cell Disease Community
Published: 2021-03-02 (Crawled : 13:03) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.2%
H: 3.42%
C: -0.81%
disease granted
Mustang Bio Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
Published: 2021-02-26 (Crawled : 13:03) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 2.61%
H: 2.82%
C: -0.28%
disease rare
Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
Published: 2021-02-26 (Crawled : 13:03) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 0.27%
H: 3.44%
C: 0.0%
disease biotech iot rare
Soleno Therapeutics Announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K(ATP) Channel Activators for the Treatment of Rare Diseases
Published: 2021-02-23 (Crawled : 13:03) - globenewswire.com
SLNO | News | $37.53 1.02% 1.01% 190K
|
Health Technology
|
| O: -2.08%
H: 0.0%
C: -5.32%
disease treatment collaboration announces collaboration rare
Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease
Published: 2021-02-16 (Crawled : 13:03) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 9.74%
H: 3.49%
C: -2.18%
disease fibrosis cystic fibrosis
GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
Published: 2021-02-04 (Crawled : 13:03) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: -1.59%
disease oxbryta
Praxis Precision Medicines Receives Rare Pediatric Disease and Orphan Drug Designations for Severe Pediatric Epilepsy Programs
Published: 2021-01-07 (Crawled : 13:03) - globenewswire.com
PRAX | $46.88 0.62% 0.62% 350K
|
Health Technology
|
| O: 0.64%
H: 4.98%
C: 3.95%
disease drug program designation rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.